Ochratoxin A homogeneous phase method for quick based on the chimeric dye fluorescence cancellation of nucleic acid
Technical field
The present invention relates to utilize the fluorescent quenching of the chimeric dyestuff of nucleic acid to detect ochratoxin A, feature is the application of ochratoxin A aptamer and the chimeric dyestuff of nucleic acid, and the detection speed of the method is fast, detection flux is high and strong operability, belongs to detection technique of fluorescence field.
Background technology
Ochratoxin A (OchratoxinA, OTA) mainly by aspergillus He Celadon mould wait generation, be widespread in nature, wherein with in the majority on the crops such as grain (wheat, corn, barley, oat, rye, rice and broomcorn millet class etc.), peanut, vegetables (beans), there are many Poisonings such as liver renal toxicity and very strong teratogenesis, carcinogenic and mutagenesis, animal and human's body health is had to very large potential hazard.Given this, detection and the control to OTA is all paid attention in countries in the world, has made one after another grain limit standard relevant with OTA in feed, as the maximum limitation of the regulation cereal materials OTA of European Union 5 μ g/kg, the maximum limitation of cereal fabricated product 3 μ g/kg; The maximum limitation of OTA 5 μ g/kg in China's regulation cereal, beans, to protect people ' s health and regulation and control to import and export grain.
The main method that detects at present OTA is thin-layered chromatography (TLC), high performance liquid chromatography (HPLC), enzyme linked immunosorbent assay (ELISA) etc.TLC method is simple, and testing cost is low, but sensitivity is poor, reappearance is bad and cannot realize robotization; HPLC method is highly sensitive, but required instrument costliness, complex pretreatment, testing cost are high, is not suitable for the rapid screening of a large amount of samples.ELISA method is highly sensitive, specificity good, but the manufacturing cycle of the high-quality antibody relying on is very long and have a problem of cross reaction.
Aptamer is as a class single stranded oligonucleotide, before and after interacting with target molecule generation specificity can there is corresponding variation in space conformation, having compared with antibody can in-vitro screening acquisition, Heat stability is good, be easy to the advantage such as chemosynthesis and modification, even can distinguish the target molecule of the single substituting group difference that monoclonal antibody cannot realize; The chimeric dyestuff of nucleic acid has following features: under free state without fluorescence or there is very weak fluorescence, be fitted to and fluorescence occurs in DNA double chain strengthen, therefore the homogeneous fluorescent detection method based on the chimeric dyestuff dyestuff of nucleic acid has highly sensitive, simple to operate and can carry out the feature such as Parallel testing of a large amount of samples.So the homogeneous fluorescent detection method that the high specific of aptamer, high-affinity are combined with the chimeric dyestuff of nucleic acid, can overcome the shortcoming of the main detection method of current OTA well, is expected to become a kind of potential quick screening method.
Summary of the invention
In order to solve, scheme complexity, the operation of current OTA detection method locked, high cost, detection time long shortcoming, the invention provides a kind of ochratoxin A homogeneous phase method for quick based on the chimeric dye fluorescence cancellation of nucleic acid.
Technical scheme of the present invention is that the ochratoxin A homogeneous phase method for quick based on the chimeric dye fluorescence cancellation of nucleic acid, comprises the following steps:
(1) formation of the chimeric dye fluorescence compound of ochratoxin A aptamer and nucleic acid;
(2) specific recognition of ochratoxin A aptamer to ochratoxin A.
The concrete operation step that the present invention is based on the ochratoxin A homogeneous phase method for quick that the chimeric dye fluorescence cancellation of nucleic acid realizes is as follows:
The formation of the chimeric dye fluorescence compound of ochratoxin A aptamer and nucleic acid
First ochratoxin A aptamer is carried out to pre-service: 95 ℃ of sex change 5min, 4 ℃ of cooling 5min.Then get 50 μ L10mM Tris-HCl reaction buffers (pH8.5), wherein the concentration of ochratoxin A aptamer is 50nM, the dilution ratio of the chimeric dyestuff of GeneFinder nucleic acid is 8:10000, room temperature reaction 30min, so that the chimeric dyestuff of nucleic acid and the abundant combination of ochratoxin A aptamer form ochratoxin A aptamer and the chimeric dye fluorescence compound of nucleic acid; Ochratoxin A aptamer is ssDNA probe, and sequence is 5 '-CTTCGGGTGTGGGTGGCATTCCGGTAGGCTCTG-3 '.
The specific recognition of ochratoxin A aptamer to ochratoxin A
In the reacted solution of above-mentioned steps (1), add appropriate ochratoxin A solution, adjusting liquor capacity with 10mM Tris-HCl reaction buffer (pH8.5) is 100 μ L, wherein the concentration of ochratoxin A aptamer is 25nM, the dilution ratio of the chimeric dyestuff of GeneFinder nucleic acid is 4:10000, room temperature reaction 5-10min, so that the abundant combination of ochratoxin A aptamer and ochratoxin A, form ochratoxin A aptamer and ochratoxin A compound, thereby cause dissociating of the chimeric dye fluorescence compound of ochratoxin A aptamer and nucleic acid, produce the variation of fluorescence intensity.Reacted solution is transferred in micro-fluorescence cuvette and puts into fluorescence spectrophotometer, or reacted solution is shifted in microwell plate and puts into the fluorescence spectrophotometer with microwell plate read module, take 490nm as excitation wavelength, 525nm is emission wavelength, the variation of measuring its fluorescence signal intensity and recording fluorescence intensity: the fluorescence intensity (I of blank
0) maximum, along with the increase fluorescence intensity (I) of OTA concentration weakens gradually.
By above-mentioned (1), (2) step, the variable concentrations ochratoxin A titer of preparation is detected, record changing value (the Δ I=I of the fluorescence intensity that each standard solution sample produces
0-I).With Δ I, to ochratoxin A concentration mapping acquisition typical curve in standard solution, the changing value of the fluorescence intensity that in unknown sample, ochratoxin A produces contrasts and determines its concentration with mark curve.
Beneficial effect imbody of the present invention is in the following areas in sum:
1) the present invention adopts ochratoxin A aptamer as molecular recognition elements, the OTA detection method that the chimeric dyestuff of nucleic acid builds as reporter molecules, greatly reduce the cost that detects OTA mycotoxin, favorable reproducibility, specificity is high, simple to operation and can realize the Parallel testing of a large amount of samples;
2) the present invention is based on the ochratoxin A homogeneous phase method for quick of the chimeric dye fluorescence cancellation of nucleic acid, after ochratoxin A aptamer and the chimeric dye fluorescence compound of nucleic acid are pre-formed, only need 5-10min can realize the detection to OTA.
Accompanying drawing explanation
Fig. 1: the phenomenon figure of the ochratoxin A homogeneous phase method for quick based on the chimeric dye fluorescence cancellation of nucleic acid: wherein (a) is GeneFinder+Aptamer+AFB1, (b) be GeneFinder+Aptamer, (c) be GeneFinder+Aptamer+OTA, (d) being GeneFinder, is (e) OTA aptamer.[OTA?aptamer]=25nM,[OTA]=[AFB1]=50nM,Dilution?ratio?of?GeneFinder=4:10000。AFB1 is aflatoxin B1.
Fig. 2: the working curve diagram that ochratoxin A standard solution is detected.
Embodiment
Below in conjunction with specific embodiment, the present invention is described in detail.
(1) formation of the chimeric dye fluorescence compound of ochratoxin A aptamer and nucleic acid
First ochratoxin A aptamer is carried out to pre-service: 95 ℃ of sex change 5min, 4 ℃ of cooling 5min.Then get 50 μ L10mM Tris-HCl reaction buffers (pH8.5), wherein the concentration of ochratoxin A aptamer is 50nM, the dilution ratio of the chimeric dyestuff of GeneFinder nucleic acid is 8:10000, room temperature reaction 30min, so that the chimeric dyestuff of nucleic acid and the abundant combination of ochratoxin A aptamer form ochratoxin A aptamer and the chimeric dye fluorescence compound of nucleic acid; Ochratoxin A aptamer is ssDNA probe, and sequence is 5 '-CTTCGGGTGTGGGTGGCATTCCGGTAGGCTCTG-3 '.
A kind of screening preparation of ochratoxin A aptamer: ochratoxin A molecule is coupled on the magnetic bead of carboxyl modified by coupling agent EDC and NHS, with the buffer solution reaction of reacting that contains initial library, initial library is fixed on magnetic bead.Respectively take the magnetic bead of carboxyl modified as anti-Screening target; make (warfarin) and ochratoxin B molecule as negative Screening target take N-acetyl group-L-Phe (N-acetyl-L-phenylalanine), method China, screen for just screening molecule with ochratoxin A.In the situation that ochratoxin A exists, there is the oligonucleotide sequence of binding ability to disintegrate down from magnetic bead with it, after pcr amplification, adopt streptavidin magnesphere partition method to prepare secondary library, repeating to screen 15 takes turns, then carry out cloning and sequencing, finally carry out sequential analysis, active detection and sequence brachymemma and optimization, thereby obtain the specific nucleic acid aptamers of ochratoxin A.
(2) specific recognition of ochratoxin A aptamer to ochratoxin A
In the reacted solution of above-mentioned steps (1), add appropriate ochratoxin A solution, adjusting liquor capacity with 10mM Tris-HCl reaction buffer (pH8.5) is 100 μ L, wherein the concentration of ochratoxin A aptamer is 25nM, the dilution ratio of the chimeric dyestuff of GeneFinder nucleic acid is 4:10000, room temperature reaction 5-10min, so that the abundant combination of ochratoxin A aptamer and ochratoxin A, form ochratoxin A aptamer and ochratoxin A compound, thereby cause dissociating of the chimeric dye fluorescence compound of ochratoxin A aptamer and nucleic acid, produce the variation of fluorescence intensity.Reacted solution is transferred in micro-fluorescence cuvette and puts into fluorescence spectrophotometer, or reacted solution is shifted in microwell plate and puts into the fluorescence spectrophotometer with microwell plate read module, take 490nm as excitation wavelength, 525nm is emission wavelength, excite slit width to be set as 10nm, transmitting slit width is set as 5nm, the variation of measuring its fluorescence signal intensity and recording fluorescence intensity: the fluorescence intensity (I of blank
0) maximum, along with the increase fluorescence intensity (I) of OTA concentration weakens gradually.
As shown in Figure 1, the chimeric dyestuff of nucleic acid (GeneFinder) autofluorescence is very weak, negligible; OTA aptamer (aptamer) self does not have fluorescence; In the two common situation about existing, form aptamer/GeneFinder fluorescent composition, have very strong fluorescence, fluorescence strengthens more than 10 times.In the situation that OTA exists, the abundant combination of aptamer and OTA, forms aptamer/OTA compound, thereby causes dissociating of aptamer/GeneFinder fluorescent composition, produces fluorescent quenching, causes fluorescence intensity to reduce; And in the situation that aflatoxin B1 (AFB1) exists, aptamer nonrecognition AFB1, therefore aptamer/GeneFinder fluorescent composition can not dissociate, so can not produce fluorescent quenching, fluorescence intensity can not reduce.
By above-mentioned (1), variable concentrations ochratoxin A titer (0nM, 1nM, 2.5nM, 5.0nM, the 7.5nM of (2) step to preparation, 10nM, 15nM, 20nM, 25nM, 35nM, 50nM, 75nM) detect, and record changing value (the Δ I=I of the fluorescence intensity that each standard solution sample produces
0-I).With Δ I, to ochratoxin A concentration mapping acquisition working curve (Fig. 2) in standard solution, the changing value of the fluorescence intensity that in unknown sample, ochratoxin A produces contrasts with working curve determines its concentration.
Should be understood that, for those of ordinary skills, can be improved according to the above description or convert, and all these improvement and conversion all should belong to the protection domain of claims of the present invention.
SEQUENCE?LISTING
<110> applicant Henan Academy of Agricultural Sciences
The ochratoxin A homogeneous phase method for quick of <120> based on the chimeric dye fluorescence cancellation of nucleic acid
<130>
<160>1
<170>PatentIn?version3.5
<210>1
<211>33
<212>DNA
<213> ochratoxin A aptamer
<400>1
cttcgggtgt?gggtggcatt?ccggtaggct?ctg
33